Prognostic Value of Albumin Levels before Therapy on Survival of Nasopharyngeal Carcinoma Patients
DOI:
https://doi.org/10.18196/mmjkk.v22i2.13893Keywords:
albumin, nasopharyngeal carcinoma, prognosis, survivalAbstract
Nasopharyngeal cancer (NPC) is a type of cancer in Southeast Asia, with 30-80 cases annually per 10,000 population. Based on the data, about 80% of patients with advanced-stage are diagnosed first, while 20% develop metastases after therapy. A prognostic assessment is essential for the optimization of treatment. Malnutrition is one of the consequences of decreased response to treatment, quality of life, and survival. The patient's albumin determines nutrition. This study was a retrospective study to evaluate the ability of pre-therapy albumin levels to predict long-term mortality in 227 NPC patients at Dr. Sardjito Hospital. Univariate analysis identified albumin as a statistically significant predictive factor for survival (P 0.021). Albumin (ALB) < 3.50 was significantly associated with shorter survival. Median Overall Survival showed (OS) ± SE ALB < 3.50 vs. ALB 3.50: 9.40 ± 2.56 vs. 17.63 ± 1.51 months, P 0.021, Hazard Ratio (HR) 1.368; 95% CI (1.049–1.783). However, multivariate analysis showed low serum albumin levels before therapy on survival in NPC patients (P 0.778, HR 1.050, 95% CI (0.75–1.469). Treatment was identified as the only independent predictive factor for survival. Albumin before therapy was a potential predictive biomarker to evaluate survival in NPC patients but not an independent predictor.References
Basem NA, Bhatt VR, Vonfrolio S, Bachir R, Rubinshteyn V, Alkaied H, et al. Value of the pretreatment albumin to globulin ratio in predicting long-term mortality in breast cancer patients. Am. J. Surg. 2013; 206(5): 764-770. https://doi.org/10.1016/j.amjsurg.2013.03.007
Kedia S, Shah N, Vonfrolio S, Lu W, Naboush A, Mohammed F, et al. The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancer, Int. J. Colorectal Dis., 2013; 28(12) https://doi.org/10.1007/s00384-013-1748-z
Chan A, Woo JKS, King A, Zee BCY, Lam L, Chan SL, et al. Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer. N. Engl. J. Med., 2017; 377(6): 513-522 https://doi.org/10.1056/NEJMoa1701717
M. A. Cupp, M. Cariolou, I. Tzoulaki, D. Aune, E. Evangelou, and A. J. Berlanga-Taylor, “Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies,” BMC Med., 18(1), 2020, https://doi.org/10.1186/s12916-020-01817-1
Cupp MA, Cariolou M, Tzoulaki I, Aune D, Evangelou E, Berlanga-Taylor AJ. Nonsteroidal antiinflammatory drugs and bladder cancer: A pooled analysis, Am. J. Epidemiol., 2011; 173(7), https://doi.org/10.1093/aje/kwq437
Du XJ, Tang LL, Mao YP, Sun Y, Zeng MS, Kang TB, et al. The pretreatment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinoma, PLoS One, 2014; 9(4), https://doi.org/10.1371/journal.pone.0094473
IARC, Breast cancer: Estimated incidence, mortality and prevalence worldwide, Globocan 2020, 419, 2020.
Wang X, Yang M, Ge Y, Tang M, Rao B, Chen Y, et al. Association of Systemic Inflammation and Malnutrition With Survival in Nasopharyngeal Carcinoma Undergoing Chemoradiotherapy: Results From a Multicenter Cohort Study, Front. Oncol., 2021;11, https://doi.org/10.3389/fonc.2021.766398
Gupta D & Lis CG, Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature, Nutrition Journal, 2010; 9(1), https://doi.org/10.1186/1475-2891-9-69
Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Shibuya N, Kubota K, Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer. Ann. Surg. Oncol. 2016;23(3): 900–907. https://doi.org/10.1245/s10434-015-4948-7
Jin Y, Ye X, He C, Zhang B, Zhang Y. Pretreatment neutrophil-to-lymphocyte ratio as predictor of survival for patients with metastatic nasopharyngeal carcinoma, Head Neck, 2015; 37(1): 69–75, https://doi.org/10.1002/hed.23565
Kamran SC, Riaz N, Lee N. Nasopharyngeal carcinoma. Surg. Oncol. Clin. N. Am., 2015; 24(3): 547–561, https://doi.org/10.1016/j.soc.2015.03.008
Kühn T, Sookthai D, Graf ME, Schübel R, Freisling H, Johnson T, et al. Albumin, bilirubin, uric acid and cancer risk: Results from a prospective population-based study, British Journal of Cancer, 2017; 117(10): 1572–1579. https://doi.org/10.1038/bjc.2017.313
Lee AWM, Ma BBY, Ng WT, Chan ATC. Management of nasopharyngeal carcinoma: Current practice and future perspective, Journal of Clinical Oncology, 2015; 33(29). https://doi.org/10.1200/JCO.2015.60.9347
Li J, Jiang R, Liu WS, Liu Q, Xu M, Feng QS, et al. A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma, PLoS One, 2013; 8(12). https://doi.org/10.1371/journal.pone.0083069
Li G, Gao J, Liu ZG, Tao YL, Xu BQ, Tu ZW, Z, et al. Influence of pretreatment ideal body weight percentile and albumin on prognosis of nasopharyngeal carcinoma: Long-term outcomes of 512 patients from a single institution. Head Neck, 2014; 36(5). https://doi.org/10.1002/hed.23357
Nakanishi Y, Masuda T, Yamaguchi K, Sakamoto S, Horimasu Y, Mimae T, et al. Albumin–globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer, Int. J. Clin. Oncol., 2020; 25(1): 74–81. https://doi.org/10.1007/s10147-019-01539-2
Peng RR , Liang ZG, Chen KH, Li L, Qu S, Zhu XD. Nomogram based on lactate dehydrogenase-to-albumin ratio (Lar) and platelet-to-lymphocyte ratio (plr) for predicting survival in nasopharyngeal carcinoma, J. Inflamm. Res., 2021; 14. https://doi.org/10.2147/JIR.S322475
Shibutani M, Maeda K, Nagahara H, Iseki Y, Hirakawa K, Ohira M. The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer, Springerplus, 2016; 5(1). https://doi.org/10.1186/s40064-016-3529-y
Xia WX, Ye YF, Lu X, Wang L, Ke LR, Zhang HB, et al. The Impact of Baseline Serum C-Reactive Protein and C-Reactive Protein Kinetics on the Prognosis of Metastatic Nasopharyngeal Carcinoma Patients Treated with Palliative Chemotherapy, PLoS One, 2013; 8(10). https://doi.org/10.1371/journal.pone.0076958
Downloads
Additional Files
Published
Issue
Section
License
Copyright
Authors retain copyright and grant Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) the right of first publication with the work simultaneously licensed under an Attribution 4.0 International (CC BY 4.0) that allows others to remix, adapt and build upon the work with an acknowledgment of the work's authorship and of the initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
Authors are permitted to copy and redistribute the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
License
Articles published in the Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) are licensed under an Attribution 4.0 International (CC BY 4.0) license. You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
This license is acceptable for Free Cultural Works. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
